MaxLinear saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, with an upgrade from 88 to 91.
Here Are 3 Keys For Successful Stock Investing
IBD's proprietary RS Rating measures technical performance by showing how a stock's price action over the last 52 weeks measures up against that of the other stocks in our database.
Over 100 years of market history reveals that the best stocks typically have an RS Rating of above 80 as they begin their biggest runs.
While MaxLinear is not near a proper buy zone right now, see if it is able to form and break out from a proper consolidation.
The company reported 0% EPS growth last quarter, while sales growth came in at 18%.
The company earns the No. 16 rank among its peers in the Electronics-Semiconductor Fabless industry group. Astera Labs, Advanced Micro Devices and Arm Holdings ADR are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Chip Stocks To Watch And Semiconductor Industry News
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
